Capricor Therapeutics reported $14.32M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Bioline Rx BLRX:US $ 9.1M 0.62M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Cytokinetics CYTK:US $ 66.84M 0M
Cytori Therapeutics CYTX:US $ 6.97M 2.05M
Geron GERN:US $ 46.63M 1.11M
Newlink Genetics NLNK:US $ 5.24M 0.11M
Prothena PRTA:US 40.11M 3.61M
Ptc Therapeutics PTCT:US $ 567.37M 90.6M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Vascular Biogenics VBLT:US 11.05M 1.12M
Vital Therapies VTL:US $ 10.4M 1.06M